CHMP-Empfehlung: Gilenya wird generisch, Novorapid bekommt

CHMP empfiehlt acht neue Arzneimittel

Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry - Transplantation and Cellular Therapy, Official Publication of the American

Novartis stoppt Gilenya-Generika

Für die MS-Basistherapie

NovoRapid receives positive CHMP opinion for extended use in children as young as one year old » FINCHANNEL

Chamomilla C 1000 Globuli, 10 g online kaufen

Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera: Molecular Therapy Methods & Clinical Development

Nobelpreis Chemie: Revolutionäre Genschere

Wegen Verwechslungsgefahr: Insulin Fiasp wird rot-gelb